Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04678440 · ClinicalTrials.gov registry record · Early Phase 1
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients
A Early Phase 1 study, sponsored by University of California, Davis.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT04678440: Completed Early Phase 1 study, sponsored by University of California, Davis.
NCT04678440 is a Early Phase 1 study that has completed, run by University of California, Davis. The registered enrollment target is 5 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04678440, a Early Phase 1 study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
In this pilot study, healthy volunteers and patients with Non-Small Cell Lung Cancer will undergo \[18F\]F-AraG dynamic imaging on the uEXPLORER total body Positron Emission Tomography/Computerized Tomography scanner to obtain preliminary data regarding pharmacokinetics and early biodistribution images.
Primary Outcome
Data on \[18F\]F-AraG uptake in several tissue types will be collected from healthy subjects. This data will be presented in the form of time-activity curves (TAC) generated for each tissue type. Quantitative assessment of \[18F\]F-AraG biodistribution in healthy tissues will be reported as a function of time as mean Standard Uptake Value (SUV)
Interventions
- DRUG [18F]F-AraG Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-03-31 |
| Est. Completion | 2023-02-07 |
| Phase | Early Phase 1 |
What the finished NCT04678440 record still lists
NCT04678440 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 1 intervention - of which [18F]F-AraG Imaging is the first listed.
NCT04678440 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04678440 about?
NCT04678440 is a clinical study titled "[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients". In this pilot study, healthy volunteers and patients with Non-Small Cell Lung Cancer will undergo \[18F\]F-AraG dynamic imaging on the uEXPLORER total body Positron Emission Tomography/Computerized Tomography scanner to obtain preliminary data regarding pharmacokinetics and early biodistribution ima...
What is the current status of trial NCT04678440?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2021-03-31. Estimated completion is 2023-02-07.
What interventions are being tested in trial NCT04678440?
The interventions under investigation include: [18F]F-AraG Imaging (DRUG).
Who is sponsoring clinical trial NCT04678440?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04678440's enrollment target sits among peer trials
5 1887th of 2000 higher than 80 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI